Body mass index triples overweight prevalence in 7600 children compared with waist-to-height ratio: the ALSPAC study - Top-Institutions - MDSpire

Body mass index triples overweight prevalence in 7600 children compared with waist-to-height ratio: the ALSPAC study

  • By

  • Andrew O Agbaje

  • February 14, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of Bristol
    University of Bristol

    Bristol, England

    Key Differentiators

    • Pediatric Obesity
    • Epidemiology
    • Metabolic Disease

  • #2

    Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health

    Boston, Massachusetts

    Key Differentiators

    • Public Health
    • Pediatric Obesity
    • Epidemiology

  • #3

    Children’s Hospital of Philadelphia (CHOP)
    Children’s Hospital of Philadelphia (CHOP)

    Philadelphia, Pennsylvania

    Key Differentiators

    • Pediatric Endocrinology
    • Obesity Medicine
    • Diabetes Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, California

    Key Differentiators

    • Pediatric Obesity
    • Endocrinology
    • Public Health

  • #5

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH

    Bethesda, Maryland

    Key Differentiators

    • Diabetes Research
    • Obesity
    • Pediatric Metabolic Health

Original Source(s)

Body mass index triples overweight prevalence in 7600 children compared with waist-to-height ratio: the ALSPAC study

  • by Andrew O Agbaje

  • February 14, 2025

Related Content

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases